Friday, July 10, 2026

Drug profile · INN

fexofenadine

fexofenadine (TELFAST) is a histamine h1 receptor antagonist. Associated with Alphapharm Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 12
News articles 0
Drug details — fexofenadine

Quick answer

fexofenadine (TELFAST) is a histamine h1 receptor antagonist. Associated with Alphapharm Pty Ltd.

Key facts

INN fexofenadine
Brand TELFAST
Mechanism Histamine H1 receptor antagonist

Mechanism of action

Histamine H1 receptor antagonist

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. 299IG301 Phase 3 · Biogen · IgA nephropathy
  2. EFC16973 Phase 3 · Sanofi-Aventis U.S · Pruritus
  3. fexofenadine HCL (M016455) Phase 3 · Sanofi Pasteur MSD · Rhinitis Seasonal
  4. mRNA 3210-P101 Phase 2 · SOM Biotech · Participants with Phenylketonuria
  5. mRNA-3745-P102 Phase 2 · SOM Biotech · Glycogen storage disease type 1a (GSD1a)
  6. Fast Dual CAR-T Injection Phase 1 · Chinese Academy of · B-cell Lymphoma
  7. Fexofenadine Phase 1 · LEXICON PHARMACEUTICALS · Drug Interactions
  8. Fexofenadine 180 mg tablets Phase 1 · Teva Pharma · Healthy

Frequently asked questions

What is fexofenadine?

fexofenadine (TELFAST) is a histamine h1 receptor antagonist. Associated with Alphapharm Pty Ltd.

What is the brand name for fexofenadine?

TELFAST is a marketed brand name for fexofenadine. Check FDA Drugs@FDA for the current US label holder and prescribing information.